Published in J Neurol Neurosurg Psychiatry on February 01, 1995
Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull (2006) 2.92
Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) (2008) 2.64
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol Dis (2009) 2.29
A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proc Natl Acad Sci U S A (2005) 1.60
Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology (Berl) (2004) 1.47
Interaction between startle and voluntary reactions in humans. Exp Brain Res (2008) 1.42
Lower prepulse inhibition in children with the 22q11 deletion syndrome. Am J Psychiatry (2005) 1.25
Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res (2009) 1.20
Advances in endophenotyping schizophrenia. World Psychiatry (2008) 1.18
Prepulse inhibition in fragile X syndrome: feasibility, reliability, and implications for treatment. Am J Med Genet B Neuropsychiatr Genet (2009) 1.16
Startle-induced reaction time shortening is not modified by prepulse inhibition. Exp Brain Res (2005) 1.15
Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP. Neuropsychopharmacology (2006) 1.15
Altered palmitoylation and neuropathological deficits in mice lacking HIP14. Hum Mol Genet (2011) 1.14
Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci (2007) 1.10
A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations. Hum Mol Genet (2011) 1.10
Associations between prepulse inhibition and executive visual attention in children with the 22q11 deletion syndrome. Mol Psychiatry (2005) 1.06
Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition. Biol Psychiatry (2007) 1.06
Fine mapping of QTL for prepulse inhibition in LG/J and SM/J mice using F(2) and advanced intercross lines. Genes Brain Behav (2010) 1.03
Effects of serotonergic and noradrenergic antidepressants on auditory startle response in patients with major depression. Psychopharmacology (Berl) (2004) 1.01
Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology (2008) 1.01
Zebrafish: An in vivo model for the study of neurological diseases. Neuropsychiatr Dis Treat (2008) 1.01
Two quantitative trait loci for prepulse inhibition of startle identified on mouse chromosome 16 using chromosome substitution strains. Genetics (2005) 1.00
Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. Am J Psychiatry (2014) 0.99
The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients. Schizophr Res (2006) 0.99
Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Curr Top Behav Neurosci (2012) 0.97
A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating. Pharmacol Biochem Behav (2007) 0.97
Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. Psychopharmacology (Berl) (2006) 0.96
Habituation and prepulse inhibition of acoustic startle in rodents. J Vis Exp (2011) 0.94
Lesions of the dorsomedial striatum disrupt prepulse inhibition. Neuroscience (2011) 0.94
Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice. Psychopharmacology (Berl) (2003) 0.94
Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor. Exp Neurol (2009) 0.92
Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system. PLoS One (2012) 0.92
The effects of memantine on prepulse inhibition. Neuropsychopharmacology (2009) 0.92
Extended access to methamphetamine self-administration affects sensorimotor gating in rats. Behav Brain Res (2010) 0.90
The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice. Psychopharmacology (Berl) (2003) 0.90
Schizophrenia: an integrative approach to modelling a complex disorder. J Psychiatry Neurosci (2006) 0.89
Uncontrollable voices and their relationship to gating deficits in schizophrenia. Schizophr Res (2008) 0.88
Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology (2011) 0.87
Ventral pallidum mediates amygdala-evoked deficits in prepulse inhibition. Behav Neurosci (2012) 0.86
Reduced startle gating after D1 blockade: effects of concurrent D2 blockade. Pharmacol Biochem Behav (2005) 0.85
PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin. Psychopharmacology (Berl) (2010) 0.85
Disruption of response inhibition circuits in prodromal Huntington disease. Cortex (2014) 0.84
Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome. Neurobiol Aging (2010) 0.84
Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats. Psychopharmacology (Berl) (2012) 0.84
Sex-dependent changes in social behaviors in motor pre-symptomatic R6/1 mice. PLoS One (2011) 0.84
Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance. Behav Brain Res (2009) 0.84
Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome. Neurosci Biobehav Rev (2012) 0.84
Moderate-level prenatal alcohol exposure enhances acoustic startle magnitude and disrupts prepulse inhibition in adult rhesus monkeys. Alcohol Clin Exp Res (2013) 0.83
Prepulse inhibition in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc (2013) 0.83
Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease. Mol Neurodegener (2011) 0.83
The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. Neuropharmacology (2007) 0.83
Onset and progression of behavioral and molecular phenotypes in a novel congenic R6/2 line exhibiting intergenerational CAG repeat stability. PLoS One (2011) 0.83
Prepulse inhibition of startle in adults with ADHD. J Psychiatr Res (2008) 0.83
Enhanced effect of dopaminergic stimulation on prepulse inhibition in mice deficient in the alpha subunit of G(z). Psychopharmacology (Berl) (2005) 0.82
Rodent models in neuroscience research: is it a rat race? Dis Model Mech (2016) 0.82
Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them. Behav Brain Res (2009) 0.81
Genetics of schizophrenia: from animal models to clinical studies. J Psychiatry Neurosci (2002) 0.81
Pre-attentive processing and schizophrenia: animal studies. Psychopharmacology (Berl) (2003) 0.80
Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system. Psychopharmacology (Berl) (2012) 0.80
Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration. BMC Neurosci (2013) 0.79
Assessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington disease. PLoS One (2013) 0.78
Psychophysiological markers of vulnerability to psychopathology in men with an extra X chromosome (XXY). PLoS One (2011) 0.78
The α₂-adrenergic antagonist idazoxan counteracts prepulse inhibition deficits caused by amphetamine or dizocilpine in rats. Psychopharmacology (Berl) (2011) 0.78
Neural correlates of sensorimotor gating: a metabolic positron emission tomography study in awake rats. Front Behav Neurosci (2014) 0.77
Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies. Neurosci Biobehav Rev (2015) 0.77
Arousal and the control of perception and movement. Curr Trends Neurol (2016) 0.76
Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L. J Exp Biol (2010) 0.76
Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice. Psychopharmacology (Berl) (2013) 0.76
Functional Dissociation of Group III Metabotropic Glutamate Receptors Revealed by Direct Comparison between the Behavioral Profiles of Knockout Mouse Lines. Int J Neuropsychopharmacol (2015) 0.75
Sensorimotor gating in healthy adults tested over a 15 year period. Biol Psychol (2016) 0.75
Genetic deletion of the Histone Deacetylase 6 exacerbates selected behavioral deficits in the R6/1 mouse model for Huntington's disease. Brain Behav (2015) 0.75
Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies. Front Neurosci (2016) 0.75
Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia. Front Psychiatry (2015) 0.75
Lamotrigine effects sensorimotor gating in WAG/Rij rats. J Neurosci Rural Pract (2012) 0.75
Neurophyisological and neurocognitive endophenotypes for schizophrenia genetics research. Psychiatry Investig (2008) 0.75
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. Front Pharmacol (2016) 0.75
Meclizine enhancement of sensorimotor gating in healthy male subjects with high startle responses and low prepulse inhibition. Neuropsychopharmacology (2013) 0.75
Dependence of the Startle Response on Temporal and Spectral Characteristics of Acoustic Modulatory Influences in Rats and Gerbils. Front Behav Neurosci (2016) 0.75
Evidence for Startle Effects due to Externally Induced Lower Limb Movements: Implications in Neurorehabilitation. Biomed Res Int (2017) 0.75
Dissociable effects of the d- and l- enantiomers of govadine on the disruption of prepulse inhibition by MK-801 and apomorphine in male Long-Evans rats. Psychopharmacology (Berl) (2017) 0.75
Effects of experimental acute tryptophan depletion on acoustic startle response in females. Eur Arch Psychiatry Clin Neurosci (2007) 0.75
Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry (1990) 4.08
Huntington disease: clinical care and evaluation. Neurology (1979) 3.54
Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology (1978) 3.08
Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science (1983) 2.79
Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology (1975) 2.76
A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci (1982) 2.73
Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry (1992) 2.72
A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry (1993) 1.52
Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain (1990) 1.44
A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement. Brain Res (1983) 1.23
Speculations on the functional anatomy of basal ganglia disorders. Annu Rev Neurosci (1983) 1.18
Men are more inhibited than women by weak prepulses. Biol Psychiatry (1993) 1.15
The measurement of abnormal movement: methods developed for Huntington's disease. Neurobehav Toxicol Teratol (1984) 1.14
Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. Arch Neurol (1978) 1.06
Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav (1993) 1.01
Habituation of the orbicularis oculi reflex in dementia and dyskinetic states. J Neurol Neurosurg Psychiatry (1978) 0.98
Prepulse inhibition of acoustic startle in rats after lesions of the pedunculopontine tegmental nucleus. Behav Neurosci (1993) 0.94
Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology (Berl) (1993) 0.92
Latency and amplitude changes in the acoustic startle reflex of the rat produced by variation in auditory prestimulation. Physiol Behav (1973) 0.91
Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berl) (1990) 0.91
GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Res (1990) 0.91
Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia. Ann Neurol (1988) 0.90
Abnormalities of the blink reflex in Gilles de la Tourette syndrome. J Neurol Neurosurg Psychiatry (1989) 0.90
Use of a neurophysiological trait in linkage analysis of schizophrenia. Biol Psychiatry (1993) 0.90
Hippocampal modulation of acoustic startle and prepulse inhibition in the rat. Pharmacol Biochem Behav (1992) 0.88
Modification of the acoustic startle reflex by a tactile prepulse: the effects of stimulus onset asynchrony and prepulse intensity. Psychophysiology (1987) 0.88
Effects of attending selectively to the spatial position of reflex-eliciting and reflex-modulating stimuli. J Exp Psychol Hum Percept Perform (1987) 0.86
Prepulse rise time and startle reflex modification: different effects for discrete and continuous prepulses. Psychophysiology (1989) 0.85
The abnormality of normal comparison groups: the identification of psychosis proneness and substance abuse in putatively normal research subjects. Am J Psychiatry (1993) 0.85
Carbachol infusion into the dentate gyrus disrupts sensorimotor gating of startle in the rat. Psychopharmacology (Berl) (1991) 0.83
On the mechanism of prepulse inhibition. Physiol Behav (1974) 0.81
Limbic lesions and the inhibition of startle reactions in the rat by conditions of preliminary stimulation. Physiol Behav (1971) 0.79
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology (1994) 5.81
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) (2001) 5.67
The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) (2001) 4.52
Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry (1990) 4.08
Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) (2001) 4.03
Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol (1992) 3.04
Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol (2000) 3.03
Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol (1991) 2.89
Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry (1992) 2.72
Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology (2000) 2.49
Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol (1992) 2.19
Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging. Clinical and neuropsychological significance. Arch Gen Psychiatry (1990) 2.18
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Am J Med Genet A (2003) 2.15
Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn (1992) 1.98
Mild cognitive impairment in prediagnosed Huntington disease. Neurology (2010) 1.96
Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry (1994) 1.90
Semantic memory impairment in Alzheimer's disease: failure of access or degraded knowledge? Neuropsychologia (1992) 1.82
Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) (1988) 1.80
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry (2004) 1.76
Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Res (1991) 1.71
Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69
Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci (1999) 1.69
Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry (2009) 1.68
Dementia in institutionalized elderly: relation to sleep apnea. J Am Geriatr Soc (1991) 1.67
Migrainous stroke. Arch Neurol (1988) 1.65
Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry (2000) 1.60
Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum (1999) 1.59
Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol Biochem Behav (1986) 1.56
Towards understanding the schizophrenia code: an expanded convergent functional genomics approach. Am J Med Genet B Neuropsychiatr Genet (2007) 1.55
Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry (2001) 1.55
Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res (2001) 1.54
Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J Neurosci (2001) 1.54
Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. Arch Neurol (1986) 1.54
Prefrontal, parietal, and temporal cortex networks underlie decision-making in the presence of uncertainty. Neuroimage (2001) 1.53
Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull (1998) 1.53
A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry (1993) 1.52
Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) (1995) 1.48
Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. II. Frontal lobe afferents. Brain Res (1975) 1.47
Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients. J Neurosci (1989) 1.46
Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up. Arch Gen Psychiatry (1994) 1.45
Cortical afferents to the entorhinal cortex of the Rhesus monkey. Science (1972) 1.45
Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull (1990) 1.44
Photic sneeze reflex in nephropathic cystinosis. Br J Ophthalmol (1990) 1.42
Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology (1995) 1.42
Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull (1987) 1.41
Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm. Biol Psychiatry (2001) 1.39
Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology (Berl) (1986) 1.38
Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology (1990) 1.38
Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry (1998) 1.38
Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn (1996) 1.36
A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Res Bull (2001) 1.36
Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry (2000) 1.35
Cerebral structure on MRI, Part II: Specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry (1991) 1.32
Impaired learning of a motor skill in patients with Huntington's disease. Behav Neurosci (1988) 1.32
Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry (2000) 1.29
Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice. Genes Brain Behav (2006) 1.28
Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry (1994) 1.27
Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol (1992) 1.27
Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology (1989) 1.26
Transient versus sustained visual channels in the visual backward masking deficits of schizophrenia patients. Biol Psychiatry (1998) 1.24
Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci (2000) 1.24
Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther (1994) 1.23
Effect of parietal lobe damage on the performance of reversible operations in space. Neuropsychologia (1970) 1.23
Cognitive loss and recovery in long-term alcohol abusers. Arch Gen Psychiatry (1983) 1.23
Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. Am J Psychiatry (1990) 1.21
Dimensionality and clustering in the semantic network of patients with Alzheimer's disease. Psychol Aging (1993) 1.20
Prepulse inhibition deficits in patients with panic disorder. Depress Anxiety (2002) 1.20
Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients. J Clin Exp Neuropsychol (1990) 1.20
Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch Gen Psychiatry (1991) 1.20
Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group. J Clin Exp Neuropsychol (1994) 1.20
Neurobiology of skill and habit learning. Curr Opin Neurobiol (1995) 1.20
Working memory in schizophrenia: transient "online" storage versus executive functioning. Schizophr Bull (2001) 1.19
The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity. Neuropharmacology (2002) 1.19
Magnetic resonance imaging of alcoholic Korsakoff patients. Neuropsychopharmacology (1991) 1.19
Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors. Mol Psychiatry (2004) 1.19
Habituation of the Blink reflex in normals and schizophrenic patients. Psychophysiology (1982) 1.19
The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci (1999) 1.18
Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization. Mol Psychiatry (2005) 1.18
Clinical validity of the Mattis Dementia Rating Scale in detecting Dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample. Arch Neurol (1995) 1.18
Transformation of the germ line into muscle in mes-1 mutant embryos of C. elegans. Development (1995) 1.18
Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychol Med (2011) 1.18
Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron (1999) 1.18
Volumetric magnetic resonance imaging quantification of longitudinal brain changes in abstinent alcoholics. Alcohol Clin Exp Res (1994) 1.17
Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry (1986) 1.17